These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 23376187
1. Halogen bonding at the ATP binding site of protein kinases: preferred geometry and topology of ligand binding. Poznański J, Shugar D. Biochim Biophys Acta; 2013 Jul; 1834(7):1381-6. PubMed ID: 23376187 [Abstract] [Full Text] [Related]
5. The role of halogen bonding in inhibitor recognition and binding by protein kinases. Voth AR, Ho PS. Curr Top Med Chem; 2007 Jul; 7(14):1336-48. PubMed ID: 17692024 [Abstract] [Full Text] [Related]
8. Evaluating the potential of halogen bonding in molecular design: automated scaffold decoration using the new scoring function XBScore. Zimmermann MO, Lange A, Boeckler FM. J Chem Inf Model; 2015 Mar 23; 55(3):687-99. PubMed ID: 25654403 [Abstract] [Full Text] [Related]
11. [Contribution of a halogen bond to binding of halogenated ligands by protein kinases]. Poznański J. Postepy Biochem; 2015 Mar 23; 61(3):311-6. PubMed ID: 26677579 [Abstract] [Full Text] [Related]
12. Halogens in Protein-Ligand Binding Mechanism: A Structural Perspective. Shinada NK, de Brevern AG, Schmidtke P. J Med Chem; 2019 Nov 14; 62(21):9341-9356. PubMed ID: 31117513 [Abstract] [Full Text] [Related]
13. Screening of protein kinases by ATP-STD NMR spectroscopy. McCoy MA, Senior MM, Wyss DF. J Am Chem Soc; 2005 Jun 08; 127(22):7978-9. PubMed ID: 15926798 [Abstract] [Full Text] [Related]
14. AMBER empirical potential describes the geometry and energy of noncovalent halogen interactions better than advanced semiempirical quantum mechanical method PM6-DH2X. Ibrahim MA. J Phys Chem B; 2012 Mar 22; 116(11):3659-69. PubMed ID: 22393912 [Abstract] [Full Text] [Related]
15. Nonbonding interactions of organic halogens in biological systems: implications for drug discovery and biomolecular design. Lu Y, Wang Y, Zhu W. Phys Chem Chem Phys; 2010 May 14; 12(18):4543-51. PubMed ID: 20428531 [Abstract] [Full Text] [Related]
17. Thermodynamic and structural characterization of halogen bonding in protein-ligand interactions: a case study of PDE5 and its inhibitors. Ren J, He Y, Chen W, Chen T, Wang G, Wang Z, Xu Z, Luo X, Zhu W, Jiang H, Shen J, Xu Y. J Med Chem; 2014 Apr 24; 57(8):3588-93. PubMed ID: 24702184 [Abstract] [Full Text] [Related]
18. Development of novel molecular probes of the Rio1 atypical protein kinase. Mielecki M, Krawiec K, Kiburu I, Grzelak K, Zagórski W, Kierdaszuk B, Kowa K, Fokt I, Szymanski S, Swierk P, Szeja W, Priebe W, Lesyng B, LaRonde-LeBlanc N. Biochim Biophys Acta; 2013 Jul 24; 1834(7):1292-301. PubMed ID: 23523885 [Abstract] [Full Text] [Related]
19. Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening. Foloppe N, Fisher LM, Howes R, Potter A, Robertson AG, Surgenor AE. Bioorg Med Chem; 2006 Jul 15; 14(14):4792-802. PubMed ID: 16574416 [Abstract] [Full Text] [Related]
20. Principles and applications of halogen bonding in medicinal chemistry and chemical biology. Wilcken R, Zimmermann MO, Lange A, Joerger AC, Boeckler FM. J Med Chem; 2013 Feb 28; 56(4):1363-88. PubMed ID: 23145854 [Abstract] [Full Text] [Related] Page: [Next] [New Search]